Oncotelic Therapeutics, Inc. (OTLC) insider trading
Oncotelic Therapeutics, Inc. insiders have made 1 open-market purchase worth $24k since Oct 30, 2026, by 1 insider. The latest: Vuong Trieu (Chair) bought $24k, filed Oct 30, 2026, scored 26 out of 100.
Follow OTLC, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 30 Form 4 (opens sec.gov) |
Vuong TrieuChairChair · Penny stock: hard to trade | +2% stake | 26 | $24k 1,356,990 at $0.02 |
— | — |
Insiders who bought OTLC
- Vuong Trieu Chair
Questions
Are insiders buying OTLC stock?
Yes. In the last 90 days, 1 open-market purchase was filed, worth $24k.
Who bought OTLC stock most recently?
Vuong Trieu, Chair, bought 1,356,990 shares for $24k (Form 4 (opens sec.gov), filed Oct 30, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Oct 30, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer